Friday 6 November 2026 Export TRLV’s income statement to Excel — free account

Trulieve Cannabis Corp.

TRLV Healthcare Drug Manufacturers Specialty & Generic

Trulieve Cannabis Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, roughly unchanged from fiscal 2024.

Revenue: −20.1%
EPS: −2,391.1%
Free cash flow: +24.5%
Total debt: −37.0%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

11.10 0.20 +1.83%

Follow TRLV

Alert me

Market cap: $2.1B
P/E: 0.0×
Fwd P/E: −5.6×
Dividend yield: —
F-score: 6/9
Altman Z: 0.98
Beneish M: −2.99
Dividend safety: n/a

Overview

Trulieve Cannabis Corp. (TRLV) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Trulieve Cannabis Corp. (TRLV) trades at a P/S ratio of 2.0×. Over the past ten years it has ranged from 0.0× (December 2021) to 4.0× (January 2022); the current reading is higher than 84% of that period. That is in line with the Drug Manufacturers Specialty & Generic industry median of 2.1× and below the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/TRLV/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Trulieve Cannabis Corp. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/TRLV/metrics/ps-ratio">Trulieve Cannabis Corp. (TRLV) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	1.4×	69.69%
FY2024	0.8×	(3.94%)
FY2023	0.9×	(23.14%)
FY2022	1.1×	(71.12%)
FY2021	3.9×	—
FY2020	0.0×	—

Period	P/S ratio	Change
Sep 2026	1.9×	16.97%
Jun 2026	1.7×	80.50%
Mar 2026	0.9×	(34.54%)
Dec 2025	1.4×	8.58%
19 more quarters	Free account

Against its own ten years

Low 0.0× High 4.0×

Ten-year median 1.1×

Current reading's percentile 82

Company	P/S ratio
HCM HUTCHMED (China) Limited Sponsored ADR compare	n/m
PRGO Perrigo Company plc compare	0.5×
ANIP ANI Pharmaceuticals, Inc. compare	1.4×
PBH Prestige Consumer Healthcare Inc. compare	1.8×
TRLV Trulieve Cannabis Corp.	2.0×
BCRX BioCryst Pharmaceuticals, Inc. compare	2.0×
ALVO Alvotech compare	4.6×
XERS Xeris Biopharma Holdings, Inc. compare	6.4×
RGC Regencell Bioscience Holdings Limited compare	—
Drug Manufacturers Specialty & Generic industry median	2.1×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Trulieve Cannabis Corp. (TRLV) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on TRLV

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on TRLV

Stockrow Weekly